TrialJournal of thrombosis and thrombolysis2014

Efficacy and safety of rivaroxaban versus low-molecular-weight heparin therapy in patients with lower limb fractures.

Anhua Long et al.PubMed ↗Publisher ↗

No numbers read from the abstract.